Line Lund Kårhus1, Janne Petersen2,3, Katja Biering Leth-Møller2, Line Tang Møllehave2, Anja Lykke Madsen4, Betina Heinsbæk Thuesen2, Peter Schwarz5,6, Jüri J Rumessen7, Allan Linneberg2,6. 1. Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Hovedvejen, Entrance 5, Nordre Fasanvej 57, 2000, Frederiksberg, Copenhagen, Denmark. line.lund.kaarhus@regionh.dk. 2. Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Hovedvejen, Entrance 5, Nordre Fasanvej 57, 2000, Frederiksberg, Copenhagen, Denmark. 3. Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. 4. The Copenhagen City Heart Study, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark. 5. Department of Endocrinology and Diabetes and Bone-Metabolic Research Unit, Rigshospitalet, Copenhagen, Denmark. 6. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 7. Q&D-Research Unit and Department of Gastroenterology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: Studies have indicated that underdiagnosis and diagnostic delay are common in celiac disease. Therefore, it is important to increase our knowledge of what symptoms and biomarkers could identify undiagnosed cases of celiac disease. METHODS: We screened for celiac disease antibodies in stored blood samples from 16,776 participants in eight population-based studies examined during 1976-2012. Undiagnosed celiac seropositivity was defined as celiac disease antibody positivity (IgG-deamidated gliadin peptide above 10.0 U/mL and/or IgA-tissue transglutaminase (TTG) or IgG-TTG above 7.0 U/mL) without a known diagnosis of celiac disease in the National Patient Register. In all studies general health symptoms were recorded by participant-completed questionnaire, including self-perceived health, tiredness, headache and gastrointestinal symptoms. Furthermore, blood samples were drawn for analyses of biomarkers e.g. hemoglobin, blood glucose, cholesterol, liver parameters and vitamins. The participants with undiagnosed celiac seropositivity were matched by sex, age and study with four controls among the celiac disease antibody negative participants. RESULTS: We excluded, five participants with known celiac disease, resulting in a population of 16,771 participants. In this population 1% (169/16,771) had undiagnosed celiac seropositivity. There were no statistically significant differences in symptoms between cases and controls. Undiagnosed celiac seropositivity was associated with low blood cholesterol (< 5 mmol/L) and low hemoglobin (< 7.3 mmol/L for women and < 8.3 mmol/L for men). CONCLUSION: In this general population study, undiagnosed cases of celiac seropositivity did not have more symptoms than controls, confirming the diagnostic difficulties of celiac disease and the low prognostic value of symptoms for a diagnosis of celiac disease. Furthermore, decreased levels of cholesterol and/or hemoglobin in the blood were associated with undiagnosed celiac seropositivity.
BACKGROUND: Studies have indicated that underdiagnosis and diagnostic delay are common in celiac disease. Therefore, it is important to increase our knowledge of what symptoms and biomarkers could identify undiagnosed cases of celiac disease. METHODS: We screened for celiac disease antibodies in stored blood samples from 16,776 participants in eight population-based studies examined during 1976-2012. Undiagnosed celiac seropositivity was defined as celiac disease antibody positivity (IgG-deamidated gliadin peptide above 10.0 U/mL and/or IgA-tissue transglutaminase (TTG) or IgG-TTG above 7.0 U/mL) without a known diagnosis of celiac disease in the National Patient Register. In all studies general health symptoms were recorded by participant-completed questionnaire, including self-perceived health, tiredness, headache and gastrointestinal symptoms. Furthermore, blood samples were drawn for analyses of biomarkers e.g. hemoglobin, blood glucose, cholesterol, liver parameters and vitamins. The participants with undiagnosed celiac seropositivity were matched by sex, age and study with four controls among the celiac disease antibody negative participants. RESULTS: We excluded, five participants with known celiac disease, resulting in a population of 16,771 participants. In this population 1% (169/16,771) had undiagnosed celiac seropositivity. There were no statistically significant differences in symptoms between cases and controls. Undiagnosed celiac seropositivity was associated with low blood cholesterol (< 5 mmol/L) and low hemoglobin (< 7.3 mmol/L for women and < 8.3 mmol/L for men). CONCLUSION: In this general population study, undiagnosed cases of celiac seropositivity did not have more symptoms than controls, confirming the diagnostic difficulties of celiac disease and the low prognostic value of symptoms for a diagnosis of celiac disease. Furthermore, decreased levels of cholesterol and/or hemoglobin in the blood were associated with undiagnosed celiac seropositivity.
Authors: S Lohi; K Mustalahti; K Kaukinen; K Laurila; P Collin; H Rissanen; O Lohi; E Bravi; M Gasparin; A Reunanen; M Mäki Journal: Aliment Pharmacol Ther Date: 2007-11-01 Impact factor: 8.171
Authors: I A Hujoel; C T Van Dyke; T Brantner; J Larson; K S King; A Sharma; J A Murray; A Rubio-Tapia Journal: Aliment Pharmacol Ther Date: 2018-03-25 Impact factor: 8.171
Authors: L U Gerdes; H Brønnum-Hansen; M Madsen; K Borch-Johnsen; T Jørgensen; A Sjøl; M Schroll Journal: J Clin Epidemiol Date: 2000-04 Impact factor: 6.437
Authors: Rok Seon Choung; Scott A Larson; Shahryar Khaleghi; Alberto Rubio-Tapia; Inna G Ovsyannikova; Katherine S King; Joseph J Larson; Brian D Lahr; Gregory A Poland; Michael J Camilleri; Joseph A Murray Journal: Gastroenterology Date: 2016-12-01 Impact factor: 22.682
Authors: Alberto Rubio-Tapia; Jonas F Ludvigsson; Tricia L Brantner; Joseph A Murray; James E Everhart Journal: Am J Gastroenterol Date: 2012-07-31 Impact factor: 10.864
Authors: Line Lund Kårhus; Margit Kriegbaum; Mia Klinten Grand; Bent Struer Lind; Line Tang Møllehave; Jüri J Rumessen; Christen Lykkegaard Andersen; Allan Linneberg Journal: Sci Rep Date: 2022-04-18 Impact factor: 4.996